ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of Bevacizumab (Avastin®) Combined to Weekly Paclitaxel Followed by Bevacizumab (Avastin®) Alone in Patients With Relapsed Ovarian Sex-cord Stromal Tumours (ALIENOR) (ALIENOR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01770301
Recruitment Status : Active, not recruiting
First Posted : January 17, 2013
Last Update Posted : June 28, 2018
Sponsor:
Collaborator:
Roche Pharma AG
Information provided by (Responsible Party):
ARCAGY/ GINECO GROUP

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : December 2017
  Estimated Study Completion Date : January 2021